Skadden advising as Endo agrees Ch11 pre-pack sale amid opioid suits

Ireland-registered pharmaceutical group Endo has sought bankruptcy protection in New York after agreeing a US$6 billion sale with noteholders – with plans to seek recognition in Canada, the UK and Australia.

Unlock unlimited access to all Global Restructuring Review content